Senior insider sale
CHIEF MEDICAL OFFICER at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$1.97M
70K shares
What this filing means
ZOJWALLA NASEEM plans to sell 70K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $1.97M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2025ACC: 0001959173-25-007864
Officer· CHIEF MEDICAL OFFICER
Since Jan 2022
70K
Shares to sell
$1.97M
Approx. market value
70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Option Granted 02/01/2024
Cash
12/19/2025
40KRestricted Stock Vesting
Compensation
11/21/2023
6.84KRestricted Stock Vesting
Compensation
11/20/2023
6.54KESPP Purchase
Cash
5/15/2023
13.61KESPP Purchase
Cash
11/15/2022
3KTotal acquired70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/19/2025 | Option Granted 02/01/2024 Cash | 40K | — |
11/21/2023 | Restricted Stock Vesting Compensation | 6.84K | — |
11/20/2023 | Restricted Stock Vesting Compensation | 6.54K | — |
5/15/2023 | ESPP Purchase Cash | 13.61K | — |
11/15/2022 | ESPP Purchase Cash | 3K | — |
| Total | 70K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
70K
Market value
$1.97M
12/19/2025
Total
Units
70K
Value
$1.97M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/19/2025 | 70K | $1.97M | NASDAQ | Planned |
| Total | 70K | $1.97M | ||